Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.

68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Conditions:   Somatostatin Receptor Positive CNS Tumors;   Meningioma;   Esthesioneuroblastoma;   Hemangioblastoma;   Medulloblastoma;   Paraganglioma;   Pituitary Adenoma
Intervention:   Diagnostic Test: Ga68-DOTATATE-PET/MRI
Sponsor:   Weill Medical College of Cornell University
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 10, 2019 / by / in
Comments